
Covishield to cost Rs 200 for govt, Rs 1000 in private market, says SII’s Adar Poonawalla
Oxford Covid-19 vaccine Covishield, manufactured by the Serum Institute of India, will be sold to the Indian government at Rs.200 per dose, SII head Adar
Oxford Covid-19 vaccine Covishield, manufactured by the Serum Institute of India, will be sold to the Indian government at Rs.200 per dose, SII head Adar
The total COVID-19 tally in India rose to 96.77 lakh, while the total number of people who have recovered from the disease reached 91.3 lakh,
India has recorded 41,810 fresh Covid-19 infections and 496 fatalities in the past 24 hours, according to the official data on Sunday. Now, the total
Serum Institute of India, the world’s largest vaccine producer, has said it has made 40 million doses of AstraZeneca’s potential COVID-19 vaccine, and will soon
India COVID-19 tally climbed to 83.64 lakh with 50,210 new cases in a day, while 77,11,809 people have recovered so far pushing the national recovery
The Serum Institute of India (SII) will produce an additional 10 crore doses of Covid-19 vaccine for India and, low and middle-income countries in 2021.